News By Tag * Ast Enzymes * Serracor * Neprinol * Inflammation * Systemic Enzyme * Scar Tissue * Circulation * Serracor-nk * Fibrinolytic * More Tags... Industry News News By Location Country(s) Industry News
| ![]() AST Enzymes | Serracor-NK: Circulatory and Inflammation SupportSerracor-NK blend of systemic enzymes supports optimal fibrin metabolism, circulatory health & normal respiratory function
By: AST Enzymes Serrapeptase and Nattokinase promote healthy inflammatory responses, help normalize fibrin levels in the circulatory system, and reduce both blood viscosity and platelet stickiness.* In 2004, Mr. Vic Rathi, president of Specialty Enzymes & Biotechnologies and master enzyme formulator and enzyme expert, developed a complete, proprietary systemic enzyme formula that later was sold under the trade name Neprinol®. Today AST Enzymes markets Serracor-NK with SEBkinase, the original systemic enzyme blend formulated by Mr. Rathi. It simply is the most advanced systemic enzyme formula for cardiovascular support available on the market today. SEBkinase®, Peptizyme SP® and NattoSEB® are registered trademarks of Specialty Enzymes and Biotechnologies, a SEB Group company. Neprinol® is a registered trademark of Arthur Andrew Medical Inc., which is not affiliated with, nor sponsors or endorses this product or any other product from Specialty Enzymes & Biotechnologies Co. and/or AST Enzymes. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure or prevent any disease. # # # AST Enzymes is a leader in enzyme therapy, offering healthcare professionals and consumers a natural, safe and highly effective therapeutic alternative for preventative care and health. AST Enzymes is a part of the SEB Group USA, a global vertically integrated company with over 50 years of experience in manufacturing, distributing, and formulating nutraceutical and industrial enzymes. With manufacturing facilities certified ISO 9001:2000 and an award-winning team of scientists and experts, the SEB Group is leading the way in systemic and digestive enzyme therapy and application. End
Page Updated Last on: Oct 08, 2010
|
|